# Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood

> **NCT03898973** · PHASE4 · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Quadrivalent inactivated influenza vaccine (IIV)

## Key facts

- **NCT ID:** NCT03898973
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-04-11
- **Primary completion:** 2023-11-17
- **Final completion:** 2023-11-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Were not able to enroll participants
- **Last updated:** 2023-11-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03898973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03898973, "Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT03898973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*